Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $65.50 $77.98 Thursday, 9th May 2024 AXSM stock ended at $73.68. This is 2.64% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 3.95% from a day low at $73.65 to a day high of $76.56.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Jan 24, 2023 $69.00 $70.81 $68.33 $70.81 698 139
Jan 23, 2023 $71.03 $73.40 $69.50 $69.75 976 858
Jan 20, 2023 $69.46 $71.24 $68.28 $70.83 970 335
Jan 19, 2023 $69.78 $73.04 $67.24 $68.05 988 105
Jan 18, 2023 $68.14 $70.21 $67.68 $70.03 762 877
Jan 17, 2023 $66.96 $69.63 $65.54 $68.19 686 003
Jan 13, 2023 $64.10 $67.67 $64.10 $67.30 1 114 237
Jan 12, 2023 $62.08 $65.00 $59.82 $64.90 1 346 159
Jan 11, 2023 $62.88 $62.88 $61.02 $62.16 1 695 115
Jan 10, 2023 $63.24 $64.96 $62.98 $63.50 703 900
Jan 09, 2023 $68.11 $68.75 $61.26 $63.32 2 233 983
Jan 06, 2023 $68.74 $70.50 $67.81 $67.99 654 800
Jan 05, 2023 $72.00 $72.85 $68.66 $69.04 1 162 519
Jan 04, 2023 $73.52 $74.46 $72.31 $73.34 724 084
Jan 03, 2023 $77.70 $77.70 $72.88 $73.32 1 089 989
Dec 30, 2022 $75.51 $77.42 $75.01 $77.13 664 216
Dec 29, 2022 $75.88 $78.90 $75.13 $76.50 834 295
Dec 28, 2022 $74.71 $76.44 $73.30 $75.00 565 040
Dec 27, 2022 $74.18 $76.96 $73.50 $75.53 645 205
Dec 23, 2022 $75.53 $76.09 $71.45 $73.79 1 007 920
Dec 22, 2022 $74.33 $75.49 $73.50 $75.13 625 663
Dec 21, 2022 $74.80 $75.92 $73.38 $74.34 752 059
Dec 20, 2022 $75.18 $76.83 $73.41 $74.65 693 481
Dec 19, 2022 $78.62 $79.10 $74.79 $75.81 978 523
Dec 16, 2022 $76.35 $79.67 $75.61 $78.40 1 175 937
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT